Luigi Nocera

16PUBLICATIONS
32CO-AUTHORS
Other creative arts and writing not elsewhere classifiedCancer diagnosisSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 15, 2025
Editorial Comment.

Luigi Nocera, Alessandro Viti

|Mar 24, 2025
Editorial Comment.

Luigi Nocera

|Apr 15, 2024
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.

Mattia Longoni, Pietro Scilipoti, Chiara Re

|Jul 09, 2023
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: analysis of individual patient data from IMvigor210 and IMvigor211 trials.

Daniele Robesti, Luigi Nocera, Federico Belladelli

|Mar 10, 2023
Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.

Mike Wenzel, Luigi Nocera, Claudia Collà Ruvolo

|Oct 03, 2022
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial.

Giuseppe Basile, Marco Bandini, Ewan A Gibb

Pageof 3

Frequent Collaborators

7 joint publications

Mike Wenzel

7 joint publications

Christoph Würnschimmel

6 joint publications

Claudia Collà Ruvolo

5 joint publications

Derya Tilki